E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 7/27/2006 in the Prospect News Biotech Daily.

Wright Medical at sector perform by RBC

Wright Medical Group Inc. was rated at sector perform, above average risk and $26 price target, by RBC Capital Markets analyst William R. Quirk after the company posted solid second-quarter results, including constant currency revenue growth of 5.8% to $87.5 million, beating RBC's $87.3 million and consensus $86.4 million expectations. Adjusted earnings per share of $0.15 beat the analyst's estimate by 1 cent. Shares of the Arlington, Tenn.-based medical device company were up 75 cents, or 3.56%, at $21.83 on volume of 365,333 shares versus the three-month running average of 346,366 shares. (Nasdaq: WMGI)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.